tiprankstipranks
Trending News
More News >
Hinge Health, Inc. Class A (HNGE)
NYSE:HNGE
US Market

Hinge Health, Inc. Class A (HNGE) Price & Analysis

Compare
152 Followers

HNGE Stock Chart & Stats

$47.25
-$1.41(-3.71%)
At close: 4:00 PM EDT
$47.25
-$1.41(-3.71%)

Bulls Say, Bears Say

Bulls Say
Guidance And Financial PerformanceManagement increased 2025 guidance across all key metrics, including raising the midpoint of its revenue outlook by 4% and raising operating income guidance by 34%.
Technology And InnovationAI innovations have materially improved Hinge Health’s MSK care platform, leading to improved clinical outcomes and increased member engagement.
ValuationHNGE's significant discount to a broader set of SMID software comps is unwarranted and this gap is expected to narrow over the next 6-12 months.
Bears Say
Customer GrowthA deceleration in customer ads was noted, with growth of +25% y/y in Q3 compared to +32% y/y in Q2.
Market ReactionShares are currently indicated off 9% in the aftermarket, as investors were positioned for a meaningful beat-and-raise quarter.
Market SentimentAs sentiment shifted to negative over the course of the week, trepidation ahead of the IPO lock up expiration grew louder.

Hinge Health, Inc. Class A News

HNGE FAQ

What was Hinge Health, Inc. Class A’s price range in the past 12 months?
Hinge Health, Inc. Class A lowest stock price was $33.42 and its highest was $62.18 in the past 12 months.
    What is Hinge Health, Inc. Class A’s market cap?
    Hinge Health, Inc. Class A’s market cap is $3.72B.
      When is Hinge Health, Inc. Class A’s upcoming earnings report date?
      Hinge Health, Inc. Class A’s upcoming earnings report date is Feb 12, 2026 which is in 53 days.
        How were Hinge Health, Inc. Class A’s earnings last quarter?
        Hinge Health, Inc. Class A released its earnings results on Nov 04, 2025. The company reported $0.422 earnings per share for the quarter, beating the consensus estimate of $0.242 by $0.18.
          Is Hinge Health, Inc. Class A overvalued?
          According to Wall Street analysts Hinge Health, Inc. Class A’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Hinge Health, Inc. Class A pay dividends?
            Hinge Health, Inc. Class A does not currently pay dividends.
            What is Hinge Health, Inc. Class A’s EPS estimate?
            Hinge Health, Inc. Class A’s EPS estimate is 0.41.
              How many shares outstanding does Hinge Health, Inc. Class A have?
              Hinge Health, Inc. Class A has 37,919,155 shares outstanding.
                What happened to Hinge Health, Inc. Class A’s price movement after its last earnings report?
                Hinge Health, Inc. Class A reported an EPS of $0.422 in its last earnings report, beating expectations of $0.242. Following the earnings report the stock price went down -15.064%.
                  Which hedge fund is a major shareholder of Hinge Health, Inc. Class A?
                  Currently, no hedge funds are holding shares in HNGE
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Hinge Health, Inc. Class A

                    Hinge Health, Inc. Class A (HNGE) is a leading digital health company focused on musculoskeletal health, primarily targeting chronic pain and related conditions. The company operates in the healthcare technology sector, providing innovative solutions that combine digital therapeutics with personalized care programs. Hinge Health's core offerings include a comprehensive platform that delivers physical therapy, exercise therapy, and behavioral health support through mobile applications and connected devices, thereby empowering patients to manage their own health effectively.

                    Hinge Health, Inc. Class A (HNGE) Earnings & Revenues

                    HNGE Company Deck

                    HNGE Earnings Call

                    Q3 2025
                    0:00 / 0:00
                    Earnings Call Sentiment|Positive
                    The earnings call highlighted significant growth in revenue, improved operational efficiency, and successful AI initiatives, indicating strong business momentum. However, there are concerns about a seasonal slowdown in Q4 and potential impacts from the federal government shutdown.View all HNGE earnings summaries

                    HNGE Stock 12 Month Forecast

                    Average Price Target

                    $67.53
                    ▲(42.92% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"39":"$39","52":"$52","65":"$65","78":"$78","91":"$91"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$90.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":67.53,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$67.53</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":59,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$59.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[39,52,65,78,91],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,47.96,51.19384615384615,54.42769230769231,57.66153846153846,60.895384615384614,64.12923076923077,67.36307692307693,70.59692307692308,73.83076923076923,77.0646153846154,80.29846153846154,83.53230769230768,86.76615384615386,{"y":90,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,47.96,49.465384615384615,50.97076923076923,52.47615384615385,53.98153846153846,55.48692307692308,56.99230769230769,58.497692307692304,60.003076923076925,61.50846153846154,63.01384615384615,64.51923076923077,66.02461538461539,{"y":67.53,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,47.96,48.80923076923077,49.65846153846154,50.50769230769231,51.356923076923074,52.206153846153846,53.05538461538462,53.90461538461538,54.753846153846155,55.60307692307693,56.45230769230769,57.30153846153846,58.15076923076923,{"y":59,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":40.16,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.45,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.45,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.31,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.95,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.68,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.75,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":49.76,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.96,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Eterna Therapeutics
                    MSP Recovery
                    Bluejay Diagnostics
                    Tivic Health Systems
                    Heart Test Laboratories, Inc.

                    Ownership Overview

                    Currently, No data available
                    ---
                    Popular Stocks